"// Clinical Research, Clinical Studies, Research"

During the past decade, Metro Boston Clinical Partners conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 3 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Metro Boston Clinical Partners" #1 sponsor was "Incyte Corporation" with 4 trials, followed by "Amgen" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Mitsubishi Tanabe Pharma America Inc." with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Metro Boston Clinical Partners" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Metro Boston Clinical Partners" are "Atopic Dermatitis" (5 trials), "Plaque Psoriasis" (3 trials), "EPP" (2 trials), "Vitiligo" (2 trials) and "XLP" (2 trials). Many other conditions were trialed in "Metro Boston Clinical Partners" in a lesser frequency.

Most popular intervention types in "Metro Boston Clinical Partners" are "Drug" (15 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Abrocitinib 200 mg" (2 trials), "Lebrikizumab" (2 trials), "Ruxolitinib cream" (2 trials) and "Vehicle" (2 trials). Other intervention names were less common.

The vast majority of trials in "Metro Boston Clinical Partners" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Metro Boston Clinical Partners". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Metro Boston Clinical Partners, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Metro Boston Clinical Partners, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".